Lupin launches Mycophenolic Acid Delayed-Release Tablets USP View	April 06, 2020
Lupin and Mylan announce Positive European Medicines Agency opinion recommending Approval of Nepexto®, Biosimilar Etanercept View	March 27, 2020
Lupin launches Betamethasone Dipropionate Ointment USP (Augmented) View	March 20, 2020
Lupin launches Ethacrynic Acid Tablets USP View	February 25, 2020
Lupin launches Moxifloxacin Ophthalmic Solution USP 0.5% View	February 14, 2020
Lupin Appoints J. Alan Butcher as Chief Corporate Development Officer View	January 10, 2020
Lupin receives approval for Betamethasone Dipropionate Ointment USP (Augmented) View	December 20, 2019
Lupin receives US FDA approval for Mycophenolic Acid Delayed-Release Tablets USP View	December 19, 2019
Lupin launches Doxercalciferol Injection View	December 19, 2019
Lupin launches Hydrocortisone Valerate Cream View	November 22, 2019
Lupin launches generic KCl for Oral Solution USP, 20 mEq View	November 19, 2019
Dr. Desh Bandhu Gupta AAiPS Award 2019 Conferred on Dr. Umesh Gupta View	November 07, 2019
Lupin receives sANDA approval from US FDA for Levothyroxine Sodium Tablets USP AB ratingto Reference Listed Drug, LEVOXYL® View	November 01, 2019
Lupin receives U.S. FDA approval for Divalproex Sodium ER Tablets USP View	October 22, 2019
Lupin launches Mycophenolate Mofetil Capsules USP View	October 04, 2019
Lupin receives U.S. FDA approval for Extended Phenytoin Sodium Capsules USP View	October 01, 2019
Lupin launches Sildenafil Tablets USP View	September 30, 2019
Lupin receives sANDA approval from U.S. FDA for Levothyroxine Sodium Tablets USP to be considered AB rated to Reference Listed Drug, UNITHROID® View	September 20, 2019
Lupin receives U.S. FDA approval for Ethacrynic Acid Tablets USP View	September 09, 2019
Lupin receives U.S. FDA approval for Fosaprepitant for Injection View	September 06, 2019
Lupin launches Fluoxetine Tablets USP View	August 22, 2019
Lupin receives U.S. FDA approval for Hydrocortisone Valerate Cream View	August 16, 2019
Lupin launches Imatinib Mesylate Tablets View	July 09, 2019
Lupin receives U.S. FDA approval for Cinacalcet Tablets View	July 03, 2019
Lupin receives U.S. FDA approval for Phenylephrine and Ketorolac Intraocular Solution View	July 03, 2019
Lupin receives tentative U.S. FDA approval for Mirabegron ER Tablets View	June 27, 2019
Lupin launches Budesonide Inhalation Suspension View	May 22, 2019
Lupin launches Clobazam Tablets View	May 10, 2019
Lupin receives tentative U.S. FDA approval for Fosaprepitant for Injection View	May 07, 2019
Lupin in alliance with Natco receives FDA approval for Bosentan Tablets View	April 30, 2019
Lupin receives FDA approval for Fluoxetine Tablets USP View	April 16, 2019
Lupin launches Testosterone Gel View	April 12, 2019
Lupin receives FDA approval for Testosterone Gel View	April 11, 2019
Lupin launches Fluoxetine Tablets USP View	April 10, 2019
Lupin launches Tadalafil Tablets USP View	April 02, 2019
Lupin launches Fluocinonide Ointment USP 0.05% View	March 28, 2019
Lupin receives FDA approval for Tadalafil Tablets USP View	March 27, 2019
Lupin receives FDA approval for Sildenafil Tablets USP View	March 25, 2019
Lupin launches generic Levothyroxine Sodium Tablets USP View	March 22, 2019
Lupin receives FDA approval for Atorvastatin Calcium Tablets USP View	March 07, 2019
Lupin in alliance with Natco receives FDA approval for Imatinib Mesylate Tablets View	March 05, 2019
Lupin receives FDA approval for Azacitidine for Injection, 100 mg Single-Dose Vial View	February 28, 2019
Lupin launches Generic Ranolazine ER Tablets in U.S. View	February 28, 2019
Lupin launches generic Minocycline Hydrochloride ER Tablets USP View	February 26, 2019
Lupin receives FDA approval for Methylprednisolone Tablets USP View	February 25, 2019
Lupin launches Clobazam Oral Suspension, 2.5mg/mL View	February 15, 2019
Lupin receives FDA approval for Fluoxetine Tablets USP View	February 12, 2019
Lupin launches Tadalafil Tablets USP View	February 12, 2019
Lupin receives FDA approval for Tadalafil Tablets USP, 20 mg View	February 07, 2019
Lupin launches Clomipramine Hydrochloride Capsules USP View	February 05, 2019
Lupin Pharmaceuticals, Inc. Issues Voluntary Recall of Ceftriaxone for Injection USP, 250mg, 500mg, 1g and 2g View	January 07, 2019
Lupin receives FDA approval for Lurasidone Hydrochloride Tablets, 20 mg, 40 mg, 60 mg, 80 mg & 120 mg View	January 07, 2019
Lupin receives FDA approval for Clobazam Oral Suspension, 2.5 mg/mL View	December 31, 2018
Lupin receives US FDA approval for Clobazam Tablets, 10 mg and 20 mg View	December 17, 2018
Lupin receives tentative US FDA approval for Tadalafil Tablets USP, 20 mg View	December 17, 2018
Lupin receives tentative US FDA approval for Dimethyl Fumarate Delayed Release Capsules, 120 mg and 240 mg View	December 13, 2018
Lupin receives tentative US FDA approval for Apixaban Tablets, 2.5 mg and 5 mg View	December 10, 2018
Lupin launches generic Silodosin Capsules 4mg and 8mg View	December 4, 2018
Lupin launches generic Nystatin and Triamcinolone Acetonide Cream USP 100,000 units/gm; 0.1% View	November 30, 2018
Lupin receives FDA approval for Clomipramine HCl Capsules View	November 26, 2018
Lupin receives FDA approval for KCl for Oral Solution 20 mEq View	November 26, 2018
Lupin launches generic Tetrabenazine Tablets View	November 21, 2018
Lupin receives FDA approval for Decitabine for Injection, 50 mg/vial, Single-Dose Vial View	November 15, 2018
Lupin receives FDA approval for Budesonide Inhalation Suspension, 0.5 mg/2 mL View	November 13, 2018
Lupin launches generic Atovaquone Oral Suspension USP in the US View	November 09, 2018
Lupin receives FDA approval for Doxercalciferol Injection, 4 mcg/2 mL (2 mcg/mL) Multi-dose Vials View	November 05, 2018
Lupin receives FDA approval for generic Triamcinolone Acetonide Ointment USP, 0.1% View	October 22, 2018
Survey Data Reveals the Need for Improved Communication Between Patients and Healthcare Providers About Bacterial Vaginosis (BV), the Most Common Gynecologic Infection in the U.S. View	October 16, 2018
Lupin receives tentative FDA approval for generic Lurasidone Hydrochloride Tablets, 20 mg, 40 mg, 60 mg, 80 mg and 120 mg View	October 15, 2018
Lupin launches generic Potassium Chloride Oral Solution USP, 20 mEq/15mL (10%) and 40 mEq/15 mL (20%) View	October 04, 2018
Lupin appoints Dr. Kamal K. Sharma as Advisor to the Company View	September 17, 2018
Lupin receives FDA approval for generic Atovaquone Oral Solution USP View	September 12, 2018
Lupin receives tentative FDA approval for generic Nudovra (Estradiol Valerate Tablets, 3 mg and 1 mg and Estradiol Valerate and Dienogest Tablets, 2 mg/2 mg and 2 mg/3 mg) Tablets View	August 22, 2018
Lupin launches generic Clobetasol Propionate Cream USP 0.05% in the US View	August 21, 2018
Lupin receives FDA approval for generic Nitrofurantoin Capsules USP (Macrocrystals), 50 mg and 100 mg View	July 12, 2018
Lupin receives FDA approval for generic Hydroxychloroquine Sulfate Tablets USP, 200 mg View	July 11, 2018
Lupin launches generic Tobramycin Inhalation Solution USP in the US View	June 13, 2018
Lupin receives FDA approval for generic Nystatin and Triamcinolone Acetonide Cream USP, 100,000 units/gram and 1mg/gram View	June 4, 2018
Lupin launches generic Methylergonovine Maleate Tabs USP in the US View	June 4, 2018
Lupin appoints Nicholas Hart as President - Specialty for US Business View	May 31, 2018
Lupin launches Solosec™ (secnidazole) 2g Oral Granules in the US View	May 31, 2018
Lupin receives FDA approval for generic Xenazine® Tablets, 12.5 mg and 25 mg View	April 23, 2018
Lupin launches generic Clobex® Spray, 0.05% in the US View	March 29, 2018
Lupin receives FDA approval for generic Clobex® Spray, 0.05% View	March 27, 2018
Lupin launches generic Lodosyn® tablets in the US View	March 26, 2018
Lupin receives FDA approval for generic Topicort Topical Spray, 0.25% View	March 19, 2018
Lupin launches generic Safyral® tablets in the US View	March 13, 2018
Lupin launches generic Axiron®s topical solution in the US View	February 26, 2018
Lupin launches generic Namenda XR® capsules in the US View	February 21, 2018
Lupin receives FDA approval for generic Tamiflu® for Oral Suspension View	February 21, 2018
Lupin launches generic Tamiflu® in the US View	February 12, 2018
Lupin launches generic Kapvay® tablets in the US View	February 8, 2018
Lupin launches generic Clobex® Lotion in the US View	February 1, 2018
Lupin launches generic Vibra-Tabs® Tablet in the US View	January 19, 2018
Lupin launches generic Ancobon® capsules in the US View	January 5, 2018
Lupin launches generic Acticlate® Tablets in the US View	November 2, 2017
Lupin Acquires Symbiomix Therapeutics LLC View	October 11, 2017
Lupin launches generic Norco® tablets in the US View	October 10, 2017
Lupin launches generic Fosrenol Chewable Tablets in the US View	August 31, 2017
Lupin launches generic Seroquel XR® tablets in the US View	August 23, 2017
Lupin launches generic Vigamox® Ophthalmic solution in the US View	July 05, 2017
Lupin launches generic Wellbutrin XL® Tablets in the US View	June 15, 2017
Lupin launches Generic Epzicom® tablets in the US View	March 29, 2017
Lupin launches Generic Minastrin® 24 Fe chewable tablets in the US View	March 16, 2017
Lupin Launches Generic Pristiq® Tablets in the US View	March 02, 2017
Lupin Launches Generic Temovate® Clobetasol Propionate Scalp Application in the US View	March 01, 2017
Lupin Launches Generic Ortho-Cyclen® 28 Tablets in the US View	January 24, 2017
Lupin Launches Generic MS Contin® ER Tablets in the US View	January 13, 2017
Lupin Receives Tentative Approval for Generic Livalo® Tablets View	December 30, 2016
Lupin Receives Tentative Approval for Generic Giazo® Tablets View	December 29, 2016
Lupin Receives Tentative Approval for Generic Benicar® Tablets View	December 26, 2016
Lupin Launches Generic Vfend® Tablets and Vfend® Oral Suspension in the US View	December 19, 2016
Lupin Receives FDA Approval for Generic Topicort® Ointment, 0.05% View	December 14, 2016
Lupin Receives FDA Approval for Generic Topicort® Ointment View	December 06, 2016
Lupin Receives Tentative Approval for Generic Zorvolex® Capsules View	December 06, 2016
Lupin Receives FDA Approval for Generic Norco® Tablets View	December 06, 2016
Lupin Receives FDA Approval for Generic Nuvigil® Tablets View	November 29, 2016
Lupin Receives Tentative Approval for Generic Epzicom® Tablets View	November 23, 2016
Lupin Launches Generic Activella® Tablets in the US View	November 15, 2016
Lupin Receives FDA Approval for Generic Ortho-Cyclen® 28 Tablets View	November 01, 2016
Lupin and Monosol Rx announce licensing agreement for multiple pediatric-focused products View	October 06, 2016
Lupin Receives FDA Approval for Generic Namenda XR® Capsules View	September 29, 2016
Lupin Receives FDA Approval for Potassium Chloride Extended-Release Capsules View	August 17, 2016
Lupin Receives FDA Approval for Generic Klor-Con® Extended-Release Tablets View	August 10, 2016
Lupin Receives Tentative Approval for Generic Lexiva® Tablets, 700 mg from US FDA View	July 27, 2016
Lupin Launches Generic Ortho Tri-Cyclen® Tablets in the US View	July 20, 2016
Lupin Receives FDA Approval for Generic Activella® Tablets View	June 22, 2016
Lupin Receives FDA Approvals for Generic Vfend® Tablets 50mg, 200mg & Vfend® Oral Suspension, 40 mg/mL View	June 06, 2016
Lupin Launches Generic Femhrt® Tablets in the US View	April 18, 2016
Lupin Launches Generic Intermezzo® Sublingual Tablets in the US View	April 05, 2016
Lupin Launches Generic Aricept® Tablets in the US View	March 31, 2016
Lupin Completes its Acquisition of GAVIS in the Us View	March 9, 2016
Lupin Launches Generic Glumetza® HCI ER Tablets in the US View	February 2, 2016
Lupin Receives FDA Approval for Generic Generess® Tablets View	January 08, 2016
Lupin Launches Generic Ortho Tri-Cyclen® Lo Tablets View	January 06, 2016
Lupin Receives FDA Approval for Generic Femhrt® Tablets View	December 28, 2015
Lupin Receives FDA Approval for Potassium Chloride Extended Release Capsules View	December 23, 2015
Lupin Receives FDA Approval for Generic Loestrin®24 Fe Tablets View	November 03, 2015
Lupin receives FDA Approval for Generic Aricept® Tablets View	November 03, 2015
Lupin Launches Generic PhosLo® in the US View	October 26, 2015
Lupin and Boehringer Ingelheim Announce Strategic Co-marketing Agreement View	October 14, 2015
Lupin launches first ever Duloxetine 40mg Delayed-Release Capsules in the US View	September 03, 2015
Lupin Announces New Center of Excellence for Inhalation Research in Florida View	August 7, 2015
Lupin Acquires Specialty Product Portfolio in Germany View	July 24, 2015
Lupin Acquires GAVIS to Expand US Generic Business View	July 23, 2015
Lupin Acquires Biocom in Russia View	July 02, 2015
Lupin Acquires Medquimica in Brazil View	May 13, 2015
Lupin Launches Generic Exforge® Tablets in the US View	April 01, 2015
LUPIN COMPLETES ACQUISTION OF PHARMA DYNAMICS, SOUTH AFRICA View	March 16, 2015
Lupin Receives US FDA Approval for Generic Lumigan® Ophthalmic Solution 0.03%. View	February 23, 2015
Lupin PR - Lupin Launches InspiraChamber Anti-Static Valved Holding Chamber Expands US Brands Portfolio View	February 18, 2015
Lupin and Celon Announce Strategic Development and Licensing Agreement for Generic Advair Diskus® View	February 17, 2015
Lupin Receives FDA Approval for Generic Vancocin® Capsules View	February 02, 2015
Lupin launches Generic DIOVAN® Tablets View	January 06, 2015
Lupin Receives FDA Approval for Generic Epivir® Tablets View	December 26, 2014
Lupin Launches Authorized Generic for Celebrex® Capsules View	December 11, 2014
Lupin Receives FDA Approval for Generic Celebrex® Capsules View	November 03, 2014
Lupin Announces Strategic Alliance for Emerging Markets View	September 16, 2014
Lupin and Salix Announce Exclusive Distribution Agreement for Canada,Zaxine®, Relistor® and Other Gastroenterology Products View	September 12, 2014
Lupin Launches Generic Cipro® for Oral Suspension in the US View	June 18, 2014
Lupin Inks Strategic Joint Venture Agreement with Yoshindo Inc.. View	April 23, 2014
Lupin Appoints Theresa Stevens as Chief Corporate Development Officer. View	April 21, 2014
Lupin Receives FDA Approval for Generic Actos® Tablets. View	April 9, 2014
Lupin Acquires Laboratorios Grin S.A. De C.V., Mexico. View	March 27, 2014
Lupin launches Generic Niaspan® Tablets in the US. View	March 21, 2014
Lupin Receives FDA Approval for Generic Monodox® Capsules and Cipro® for Oral Suspension. View	March 06, 2014
Lupin Receives FDA Approval for Generic Mycobutin® Capsules. View	Feb 26, 2014
Lupin Appoints Dr. Maurice Chagnaud as President-Europe & Head of Inhalation Strategy View	Feb 18, 2014
Lupin Acquires Nanomi B.V. Enters Complex Injectables Space View	Feb 3, 2014
Strong Growth, Record Profits Quarter III Results, FY 2013-14 Net Sales up 21%, EBITDA up 28%, Net profit up 42% Declares Interim Dividend of 150% View	Feb 3, 2014
Lupin launches Generic Trizivir® Tablets View	Dec 18, 2013
Lupin launches Generic Cymbalta® Delayed-Release Capsules 20 mg, 30 mg and 60 mg strengths in the US View	Dec 12, 2013
Lupin Receives FDA Approval for Generic Trizivir® Tablets View	Dec 10, 2013
Lupin launches Generic Trilipix® Delayed - Release Capsules 45 mg & 135 mg in the US View	Dec 06, 2013
Lupin launches Generic Aciphex® Delayed-Release Tablets, 20 mg in the US View	Nov 11, 2013
Lupin Receives FDA Approval for its New Drug Application for Antara® Capsules View	Oct 22, 2013
Lupin launches Generic ZYMAXID™ Ophthalmic solution in the US View	Oct 3, 2013
Lupin Receives FDA Approval for Generic Ambien CR® Extended-release Tablets View	Sept 16, 2013
Lupin receives FDA Approval for Generic Ranexa® Extended-release Tablets View	Aug 1, 2013
Lupin Receives Tentative FDA Approvals for Generic Nuvigil® Tablets and Generic Oracea® Capsules View	Jul 31, 2013
Lupin receives FDA approval for its Oral Contraceptive Pirmella™ 7/7/7 and Pirmella™ 1/35 Tablets View	Apl 26, 2013
Lupin announces favorable ruling for generic Yaz® Oral Contraceptive Tablets View	Apl 17, 2013
Lupin launches its Oral Contraceptive DayseeTM Tablets in the US Market Generic of Seasonique® Tablets View	Apl 12, 2013
Lupin Launches Generic Diovan HCT® Tablets View	Mar 22, 2013
Lupin to launch Generic Yasmin® Tablets; receives FDA approval View	Dec 19, 2012
Lupin launches Generic TRICOR® Tablets View	Nov 20, 2012
Lupin Launches Fenofibrate Tablets, AB rated to Tricor® View	Nov 20, 2012
Lupin launches Generic Seasonale® Tablets; receives FDA approval View	Oct 25, 2012
Lupin receives FDA approval for its Oral Contraceptive Kurvelo® Tablets; The Generic of Nordette® Tablets View	Oct 18, 2012
Lupin receives FDA approval for Generic Lexapro® Tablets View	July 03, 2012
Lupin receives FDA approval for Generic Ortho Tri-cyclen Lo ® Tablets View	July 03, 2012
Lupin Launches Generic Combivir® Tablets View	May 15, 2012
Lupin Resumes Sales of Generic Fortamet® View	April 19, 2012
Lupin launches Generic SEROQUEL® Tablets Receives final FDA Approval for its Generic SEROQUEL® Tablets View	March 28, 2012
Lupin launches Generic Geodon® Capsules Receives final FDA Approval for its Generic Geodon® Capsules View	March 03, 2012
Lupin Announces U.S. FDA Approval of its First Oral Contraceptive View	Sept 16, 2011
Lupin Announces Launch of Generic KEPPRA XR® Tablets View	Sept 12, 2011
Lupin Announces Launch of Generic Version of Ponstel® Capsules View	Sept 06, 2011
Lupin Receives Final Approval to Market Generic Ultram® ER View	Aug 29, 2011
Lupin Launches Additional Strengths of Generic Lotrel® Capsules View	July 06, 2011
Lupin Announces Launch of Generic Levaquin® Tablets for the US Market View	Jun 22, 2011
HDMA Honors Lupin with DIANA Award for Best Overall Generic Manufacturer View	Jun 08, 2011
Lupin Announces Final FDA Approval of Generic Hyzaar® and Cozaar® View	Oct 06, 2010
Lupin receives FDA approval for Famotidine for Oral Suspension View	Jun 29, 2010
Lupin receives FDA approval for Imipramine Pamoate Capsules View	Apr 16, 2010
Lupin receives FDA tentative approval for Eszopiclone tablets View	Mar 20, 2010
Lupin receives FDA approval for Amlodipine/Benazepril capsules View	Feb 08, 2010
Lupin receives FDA approval for Perindopril Erbumine Tablets View	Jan 28, 2010
Lupin receives FDA tentative approval for Memantine HCl tablets View	Jan 19, 2010
Lupin is granted USFDA approval for Levetiracetam Tablets View	Jan 16, 2009